Reminder: Invitation to Roche’s 3rd Quarter Sales 2020 Webinar Donnerstag, 08. Oktober 2020 - 10:03

Roche will publish its Sales Results for the 3rd Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, October 15th, 2020.

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here
Presentation slides will be posted on the Roche IR website > click here

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

• Severin Schwan, CEO Roche Group
• Bill Anderson, CEO Roche Pharmaceuticals
• Thomas Schinecker, CEO Roche Diagnostics
• Alan Hippe, Chief Financial and IT Officer
  
  
  

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com
*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations

Roche Investor Relations

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com

Investor Relations North America

Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com

Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com